NBIX NEUROCRINE BIOSCIENCES INC
Nasdaq · SEC CIK 914475 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $77.87M 26 sales by 15 insiders
- Filings on record
- 361 since 2021-07-29, latest 2026-09-15 17:07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| Cooke Julie | CHRO | — | $5.77M |
| Gano Kyle | CEO, Dir | — | $4.87M |
| Lippoldt Darin | CLO | — | $4.20M |
| SHERWIN STEPHEN A | Dir | — | $4.13M |
| Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| Onyia Jude | CSO | — | $3.47M |
| RASTETTER WILLIAM H | Dir | — | $2.73M |
| POPS RICHARD F | Dir | — | $2.36M |
| LYONS GARY A | Dir | — | $2.29M |
Transactions 470
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-02 | 2023-01-31 | NBIX | Cooke Julie | CHRO | S - Sale | $108.48 | -916 | 15.9K | -5% | -$99.4K | |
| 2023-02-02 | 2023-01-31 | NBIX | Onyia Jude | CSO | S - Sale | $108.48 | -126 | 2,477 | -5% | -$13.7K | |
| D | 2023-01-10 | 2023-01-06 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $43.24 | +400 | 16.0K | +3% | +$17.3K |
| D | 2023-01-10 | 2023-01-06 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $125.00 | -400 | 15.6K | -2% | -$50.0K |
| DM | 2023-01-05 | 2023-01-03 | NBIX | SHERWIN STEPHEN A | Dir | S - Sale+OE | $118.86 | -30.0K | 25.1K | -54% | -$3.57M |
| DM | 2023-01-05 | 2023-01-03 | NBIX | SHERWIN STEPHEN A | Dir | M - OptEx | $12.85 | +30.0K | 40.1K | +298% | +$385.4K |
| D | 2023-01-05 | 2023-01-03 | NBIX | POPS RICHARD F | Dir | M - OptEx | $12.71 | +15.0K | 44.5K | +51% | +$190.7K |
| D | 2023-01-05 | 2023-01-03 | NBIX | POPS RICHARD F | Dir | S - Sale+OE | $119.20 | -15.0K | 29.5K | -34% | -$1.79M |
| DM | 2022-12-01 | 2022-11-30 | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $41.47 | +50.0K | 35.7K | New | +$2.07M |
| DM | 2022-12-01 | 2022-11-30 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $125.90 | -50.0K | 15.6K | -76% | -$6.29M |
| 2022-12-01 | 2022-11-29 | NBIX | Onyia Jude | CSO | S - Sale | $121.90 | -2,331 | 2,366 | -50% | -$284.1K | |
| D | 2022-11-10 | 2022-11-08 | NBIX | Cooke Julie | CHRO | S - Sale+OE | $124.99 | -5,592 | 15.1K | -27% | -$698.9K |
| D | 2022-11-10 | 2022-11-08 | NBIX | Cooke Julie | CHRO | M - OptEx | $81.05 | +5,592 | 20.7K | +37% | +$453.2K |
| D | 2022-11-10 | 2022-11-08 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $125.04 | -5,082 | 29.2K | -15% | -$635.5K |
| D | 2022-11-10 | 2022-11-08 | NBIX | Lippoldt Darin | CLO | M - OptEx | $43.24 | +5,082 | 34.3K | +17% | +$219.7K |
| DM | 2022-11-10 | 2022-11-08+ | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $41.78 | +24.7K | 15.7K | New | +$1.03M |
| DM | 2022-11-10 | 2022-11-08+ | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $125.33 | -24.7K | 15.6K | -61% | -$3.09M |
| DM | 2022-11-04 | 2022-11-02+ | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale+OE | $125.02 | -9,368 | 15.6K | -37% | -$1.17M |
| DM | 2022-11-04 | 2022-11-02+ | NBIX | BENEVICH ERIC | Chief Commercial Off | M - OptEx | $41.78 | +9,368 | 16.0K | +140% | +$391.4K |
| D | 2022-11-04 | 2022-11-03 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $125.02 | -4,518 | 29.2K | -13% | -$564.8K |
| D | 2022-11-04 | 2022-11-03 | NBIX | Lippoldt Darin | CLO | M - OptEx | $43.24 | +4,518 | 33.8K | +15% | +$195.4K |
| DM | 2022-11-04 | 2022-11-02+ | NBIX | Cooke Julie | CHRO | S - Sale+OE | $125.00 | -8,408 | 15.1K | -36% | -$1.05M |
| DM | 2022-11-04 | 2022-11-02+ | NBIX | Cooke Julie | CHRO | M - OptEx | $81.05 | +8,408 | 16.2K | +107% | +$681.5K |
| D | 2022-11-02 | 2022-10-31 | NBIX | LYONS GARY A | Dir | M - OptEx | $12.71 | +15.0K | 218.7K | +7% | +$190.7K |
| D | 2022-11-02 | 2022-10-31 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $114.76 | -15.0K | 203.7K | -7% | -$1.72M |
| DM | 2022-11-02 | 2022-11-01+ | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $120.28 | -10.4K | 29.2K | -26% | -$1.25M |
| DM | 2022-11-02 | 2022-11-01+ | NBIX | Lippoldt Darin | CLO | M - OptEx | $43.24 | +10.4K | 39.2K | +36% | +$449.7K |
| 2022-11-02 | 2022-10-31 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $114.12 | -1,295 | 2,919 | -31% | -$147.8K | |
| DM | 2022-10-28 | 2022-10-26+ | NBIX | Lippoldt Darin | CLO | M - OptEx | $43.24 | +10.0K | 34.2K | +41% | +$432.4K |
| DM | 2022-10-28 | 2022-10-26+ | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $115.03 | -10.0K | 29.2K | -25% | -$1.15M |
| 2022-10-19 | 2022-10-17 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $110.82 | -4,960 | 15.6K | -24% | -$549.7K | |
| 2022-10-05 | 2022-10-03 | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $106.59 | -1,437 | 4,214 | -25% | -$153.2K | |
| 2022-10-05 | 2022-10-04 | NBIX | LYONS GARY A | Dir | S - Sale | $110.54 | -5,000 | 203.7K | -2% | -$552.7K | |
| D | 2022-10-05 | 2022-10-04 | NBIX | Lippoldt Darin | CLO | M - OptEx | $43.24 | +10.0K | 39.2K | +34% | +$432.4K |
| D | 2022-10-05 | 2022-10-04 | NBIX | Lippoldt Darin | CLO | S - Sale+OE | $111.04 | -10.0K | 29.2K | -25% | -$1.11M |
| M | 2022-09-09 | 2022-09-07+ | NBIX | Lippoldt Darin | CLO | G - Gift | $0.00 | -200 | 29.3K | -0.7% | $0 |
| DM | 2022-08-16 | 2022-08-12+ | NBIX | Lloyd-Smith Malcolm | Chief Regulatory Off | M - OptEx | $38.70 | +29.6K | 26.9K | New | +$1.14M |
| D | 2022-08-16 | 2022-08-12 | NBIX | Lloyd-Smith Malcolm | Chief Regulatory Off | S - Sale+OE | $105.95 | -21.5K | 18.9K | -53% | -$2.28M |
| 2022-08-09 | 2022-08-05 | NBIX | Cooke Julie | CHRO | S - Sale | $100.00 | -1,816 | 15.1K | -11% | -$181.6K | |
| 2022-06-29 | 2022-06-27 | NBIX | Cooke Julie | CHRO | S - Sale | $100.00 | -754 | 16.9K | -4% | -$75.4K | |
| DM | 2022-05-11 | 2022-05-09 | NBIX | POPS RICHARD F | Dir | M - OptEx | $6.66 | +15.0K | 37.0K | +68% | +$99.9K |
| DM | 2022-05-11 | 2022-05-09 | NBIX | POPS RICHARD F | Dir | S - Sale+OE | $76.30 | -15.0K | 29.5K | -34% | -$1.14M |
| D | 2022-04-27 | 2022-04-25 | NBIX | LYONS GARY A | Dir | S - Sale+OE | $92.76 | -15.0K | 208.7K | -7% | -$1.39M |
| D | 2022-04-27 | 2022-04-25 | NBIX | LYONS GARY A | Dir | M - OptEx | $6.66 | +15.0K | 223.7K | +7% | +$99.9K |
| D | 2022-04-05 | 2022-04-01 | NBIX | RASTETTER WILLIAM H | Dir | S - Sale+OE | $94.93 | -10.7K | 34.0K | -24% | -$1.02M |
| D | 2022-04-05 | 2022-04-01 | NBIX | RASTETTER WILLIAM H | Dir | M - OptEx | $6.66 | +20.0K | 44.8K | +81% | +$133.2K |
| M | 2022-03-22 | 2022-03-18+ | NBIX | Lippoldt Darin | CLO | S - Sale | $95.05 | -8,755 | 29.4K | -23% | -$832.1K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $80.45 | -3,724 | 23.7K | -14% | -$299.6K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | Gano Kyle | Chief Business Development Off | S - Sale | $80.62 | -6,880 | 105.6K | -6% | -$554.6K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | ABERNETHY MATT | CFO | S - Sale | $80.53 | -4,290 | 19.3K | -18% | -$345.5K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | Boyer David W. | Chief Corp. Affairs Off | S - Sale | $79.99 | -940 | 2,291 | -29% | -$75.2K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | Lloyd-Smith Malcolm | Chief Regulatory Off | S - Sale | $80.48 | -3,382 | 18.7K | -15% | -$272.2K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | Lippoldt Darin | CLO | S - Sale | $80.45 | -4,079 | 38.1K | -10% | -$328.2K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | GORMAN KEVIN CHARLES | CEO, Dir | S - Sale | $80.54 | -11.0K | 462.8K | -2% | -$884.7K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | Cooke Julie | CHRO | S - Sale | $80.38 | -2,858 | 17.4K | -14% | -$229.7K |
| M | 2022-02-09 | 2022-02-07+ | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $80.57 | -5,099 | 19.5K | -21% | -$410.8K |
| D | 2022-01-26 | 2022-01-24 | NBIX | SHERWIN STEPHEN A | Dir | M - OptEx | $6.66 | +15.0K | 40.1K | +60% | +$99.9K |
| D | 2022-01-26 | 2022-01-24 | NBIX | SHERWIN STEPHEN A | Dir | S - Sale+OE | $74.43 | -15.0K | 25.1K | -37% | -$1.12M |
| 2022-01-12 | 2022-01-10 | NBIX | ROBERTS EIRY | Chief Medical Off | S - Sale | $74.50 | -2,632 | 21.3K | -11% | -$196.1K | |
| D | 2022-01-07 | 2022-01-05 | NBIX | Gano Kyle | Chief Business Development Off | S - Sale+OE | $85.50 | -28.3K | 105.0K | -21% | -$2.42M |
| D | 2022-01-07 | 2022-01-05 | NBIX | Gano Kyle | Chief Business Development Off | M - OptEx | $8.66 | +28.3K | 133.2K | +27% | +$244.8K |
| 2021-12-16 | 2021-12-14 | NBIX | Dir | G - Gift | $0.00 | -2,000 | 25.1K | -7% | $0 | ||
| 2021-12-14 | 2021-12-10 | NBIX | Lippoldt Darin | CLO | G - Gift | $0.00 | -120 | 34.4K | -0.3% | $0 | |
| 2021-12-03 | 2021-12-01 | NBIX | ABERNETHY MATT | CFO | S - Sale | $82.59 | -1,645 | 16.3K | -9% | -$135.9K | |
| D | 2021-10-12 | 2021-10-07 | NBIX | Grigoriadis Dimitri E. | Chief Research Off | M - OptEx | $43.24 | +5,000 | 87.3K | +6% | +$216.2K |
| DM | 2021-10-12 | 2021-10-07 | NBIX | Grigoriadis Dimitri E. | Chief Research Off | S - Sale+OE | $104.81 | -8,000 | 82.3K | -9% | -$838.5K |
| 2021-10-12 | 2021-10-07 | NBIX | LYONS GARY A | Dir | S - Sale | $105.06 | -5,000 | 208.7K | -2% | -$525.3K | |
| 2021-10-06 | 2021-10-04 | NBIX | Cooke Julie | CHRO | S - Sale | $101.73 | -987 | 14.8K | -6% | -$100.4K | |
| 2021-08-18 | 2021-08-16 | NBIX | BENEVICH ERIC | Chief Commercial Off | S - Sale | $89.62 | -5,628 | 15.6K | -27% | -$504.4K | |
| 2021-07-29 | 2021-07-27 | NBIX | Lloyd-Smith Malcolm | Chief Regulatory Off | S - Sale | $93.80 | -16.7K | 15.8K | -51% | -$1.57M |
Purchase Sale Sale after option exercise All abbreviations